Table of Contents Author Guidelines Submit a Manuscript
Biochemistry Research International
Volume 2016 (2016), Article ID 3137010, 14 pages
http://dx.doi.org/10.1155/2016/3137010
Research Article

Para-Phenylenediamine Induces Apoptotic Death of Melanoma Cells and Reduces Melanoma Tumour Growth in Mice

1Department of Biochemistry, University of Calcutta, 35 Ballygunge Circular Road, Kolkata 700 019, India
2Cytometry Solutions Pvt Ltd., Tripti Mitra’s Garden, Balia Garia Station Road, Kolkata, West Bengal 700084, India
3Cancer & Cell Biology Division, CSIR-Indian Institute of Chemical Biology, 4 Raja SC Mullick Road, Kolkata, West Bengal 700032, India

Received 27 November 2015; Revised 28 March 2016; Accepted 4 April 2016

Academic Editor: Graham Côté

Copyright © 2016 Debajit Bhowmick et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. S. Soengas and S. W. Lowe, “Apoptosis and melanoma chemoresistance,” Oncogene, vol. 22, no. 20, pp. 3138–3151, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Guida, S. Pisconte, and G. Colucci, “Metastatic melanoma: the new era of targeted therapy,” Expert Opinion on Therapeutic Targets, vol. 16, no. 2, pp. S61–S70, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Kyrgidis, A. Valasidis, E. Bourlidou, and C. Andreadis, “Better targeting melanoma: options beyond surgery and conventional chemotherapy,” Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, vol. 5, no. 2, pp. 147–159, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Pinon, Y. Limami, L. Micallef et al., “A novel form of melanoma apoptosis resistance: melanogenesis up-regulation in apoptotic B16-F0 cells delays ursolic acid-triggered cell death,” Experimental Cell Research, vol. 317, no. 12, pp. 1669–1676, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. L. A. Stanley, J. A. Skare, E. Doyle, R. Powrie, D. D'Angelo, and C. R. Elcombe, “Lack of evidence for metabolism of p-phenylenediamine by human hepatic cytochrome P450 enzymes,” Toxicology, vol. 210, no. 2-3, pp. 147–157, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. S. A. Devos and P. G. M. Van Der Valk, “The risk of active sensitization to PPD,” Contact Dermatitis, vol. 44, no. 5, pp. 273–275, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. M. J. Thun, S. F. Altekruse, M. M. Namboodiri, E. E. Calle, D. G. Myers, and C. W. Heath Jr., “Hair dye use and risk of fatal cancers in U.S. women,” Journal of the National Cancer Institute, vol. 86, no. 3, pp. 210–215, 1994. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Gago-Dominguez, J. Esteban Castelao, J.-M. Yuan, M. C. Yu, and R. K. Ross, “Use of permanent hair dyes and bladder-cancer risk,” International Journal of Cancer, vol. 91, no. 4, pp. 575–579, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. J. M. Sontag, “Carcinogenicity of substituted-benzenediamines (phenylenediamines) in rats and mice,” Journal of the National Cancer Institute, vol. 66, no. 3, pp. 591–602, 1981. View at Google Scholar · View at Scopus
  10. G. H. Rauscher, D. Shore, and D. P. Sandler, “Hair dye use and risk of adult acute leukemia,” American Journal of Epidemiology, vol. 160, no. 1, pp. 19–25, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Yokozeki, K. Watanabe, K. Igawa, Y. Miyazaki, I. Katayama, and K. Nishioka, “Gammadelta T cells assist alphabeta T cells in the adoptive transfer of contact hypersensitivity to para-phenylenediamine,” Clinical Experimental Immunology, vol. 125, no. 3, pp. 351–359, 2001. View at Google Scholar
  12. M. K. Bharali and K. Dutta, “Testicular toxicity of para-phenylenediamine after subchronic topical application in rat,” International Journal of Environmental Health Research, vol. 22, no. 3, pp. 270–278, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Rojanapo, P. Kupradinun, A. Tepsuwan, S. Chutimataewin, and M. Tanyakaset, “Carcinogenicity of an oxidation product of p-phenylenediamine,” Carcinogenesis, vol. 7, no. 12, pp. 1997–2002, 1986. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Bonifas, S. Scheitza, J. Clemens, and B. Blömeke, “Characterization of N-acetyltransferase 1 activity in human keratinocytes and modulation by para-phenylenediamine,” Journal of Pharmacology and Experimental Therapeutics, vol. 334, no. 1, pp. 318–326, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Kawakubo, H. F. Merk, T. A. Masaoudi, S. Sieben, and B. Blömeke, “N-acetylation of paraphenylenediamine in human skin and keratinocytes,” Journal of Pharmacology and Experimental Therapeutics, vol. 292, no. 1, pp. 150–155, 2000. View at Google Scholar · View at Scopus
  16. B. Blömeke, T. Pietzsch, and H. F. Merk, “Elicitation response characteristics to mono- and to N,N′-diacetyl-para-phenylenediamine,” Contact Dermatitis, vol. 58, no. 6, pp. 355–358, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. S.-C. Chen, C.-H. Chen, C.-L. Chern et al., “p-phenylenediamine induces p53-mediated apoptosis in Mardin-Darby canine kidney cells,” Toxicology in Vitro, vol. 20, no. 6, pp. 801–807, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. S. C. Chen, C. H. Chen, Y. L. Tioh, P. Y. Zhong, Y. S. Lin, and S. M. Chye, “Para-phenylenediamine induced DNA damage and apoptosis through oxidative stress and enhanced caspase-8 and -9 activities in Mardin-Darby canine kidney cells,” Toxicology in Vitro, vol. 24, no. 4, pp. 1197–1202, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. T. W. Salcedo and H. B. Fleit, “Detection of tumor necrosis factor induced nuclear damage with p-phenylenediamine,” Journal of Immunological Methods, vol. 148, no. 1-2, pp. 209–216, 1992. View at Publisher · View at Google Scholar · View at Scopus
  20. A. E. Radulescu, A. Siddhanta, and D. Shields, “A role for clathrin in reassembly of the Golgi apparatus,” Molecular Biology of the Cell, vol. 18, no. 1, pp. 94–105, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. T. P. M. Akerboom and H. Sies, “Assay of glutathione, glutathione disulphide, and glutathione mixed disulphides in biological samples,” Methods in Enzymology, vol. 77, pp. 373–382, 1981. View at Publisher · View at Google Scholar
  22. H. Aebi, “Catalase in vitro,” Methods in Enzymology, vol. 105, pp. 121–126, 1984. View at Publisher · View at Google Scholar · View at Scopus
  23. J. H. Yu, C. Y. Liu, G. B. Zheng et al., “Pseudolaric acid B induced cell cycle arrest, autophagy and senescence in murine fibrosarcoma L929 cell,” International Journal of Medical Sciences, vol. 10, no. 6, pp. 707–718, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Kumar and M. Dikshit, Flow Cytometry Lab Protocols: Protocols from the International Cytometry Workshops, CreateSpace Independent Publishing Platform, 2010.
  25. J. T. Litfield and F. Wilcoxon, “A simplified method of evaluating dose-effect experiments,” Journal of Pharmacology and Experimental Therapeutics, vol. 96, no. 2, pp. 99–113, 1949. View at Google Scholar
  26. J. Geier, B. K. Ballmer-Weber, H. Dickel et al., “Monitoring contact sensitization to p-phenylenediamine (PPD) by patch testing with PPD 0.3% in petrolatum,” Contact Dermatitis, vol. 69, no. 1, pp. 26–31, 2013. View at Publisher · View at Google Scholar
  27. H. Yokozeki, M.-H. Wu, K. Sumi et al., “Th2 cytokines, IgE and mast cells play a crucial role in the induction of para-phenylenediamine-induced contact hypersensitivity in mice,” Clinical and Experimental Immunology, vol. 132, no. 3, pp. 385–392, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. J. P. Thyssen and J. M. L. White, “Epidemiological data on consumer allergy to p-phenylenediamine,” Contact Dermatitis, vol. 59, no. 6, pp. 327–343, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. FDA Approved Drugs for Oncology, November 2015, http://www.centerwatch.com/drug-information/fda-approvals/drug-areas.aspx?AreaID=12.
  30. A. H. Boulares, A. G. Yakovlev, V. Ivanova et al., “Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells,” The Journal of Biological Chemistry, vol. 274, no. 33, pp. 22932–22940, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. D. R. Raleigh and D. A. Haas-Kogan, “Molecular targets and mechanisms of radiosensitization using DNA damage response pathways,” Future Oncology, vol. 9, no. 2, pp. 219–233, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Brown, M. G. Cascio, D. Rotondo, R. G. Pertwee, S. D. Heys, and K. W. J. Wahle, “Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators,” Progress in Lipid Research, vol. 52, no. 1, pp. 80–109, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. J. A. Pietenpol and Z. A. Stewart, “Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis,” Toxicology, vol. 181-182, pp. 475–481, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. S. N. Willis and J. M. Adams, “Life in the balance: how BH3-only proteins induce apoptosis,” Current Opinion in Cell Biology, vol. 17, no. 6, pp. 617–625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Dewson and R. M. Kluck, “Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosis,” Journal of Cell Science, vol. 122, no. 16, pp. 2801–2808, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. P. G. Ekert, J. Silke, and D. L. Vaux, “Caspase inhibitors,” Cell Death and Differentiation, vol. 6, no. 11, pp. 1081–1086, 1999. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Bhattacharjee, D. Ershov, K. Fytianos et al., “Cytotoxicity and cellular uptake of tri-block copolymer nanoparticles with different size and surface characteristics,” Particle and Fibre Toxicology, vol. 9, article 11, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Morabito, S. Condello, M. Currò, A. Marino, R. Ientile, and G. La Spada, “Oxidative stress induced by crude venom from the jellyfish Pelagia noctiluca in neuronal-like differentiated SH-SY5Y cells,” Toxicology in Vitro, vol. 26, no. 5, pp. 694–699, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Mei, H. Gu, X. Yang, H. Guo, Z. Liu, and W. Cao, “Prolonged exposure to insulin induces mitochondrion-derived oxidative stress through increasing mitochondrial cholesterol content in hepatocytes,” Endocrinology, vol. 153, no. 5, pp. 2120–2129, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. C.-J. Chen and S. Makino, “Murine coronavirus-induced apoptosis in 17Cl-1 cells involves a mitochondria-mediated pathway and its downstream caspase-8 activation and bid cleavage,” Virology, vol. 302, no. 2, pp. 321–332, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. B. M. Kim and H. W. Chung, “Hypoxia/reoxygenation induces apoptosis through a ROS-mediated caspase-8/Bid/Bax pathway in human lymphocytes,” Biochemical and Biophysical Research Communications, vol. 363, no. 3, pp. 745–750, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. B. M. Kim, Y. J. Choi, Y. Han, Y.-S. Yun, and S. H. Hong, “N,N-dimethyl phytosphingosine induces caspase-8-dependent cytochrome c release and apoptosis through ROS generation in human leukemia cells,” Toxicology and Applied Pharmacology, vol. 239, no. 1, pp. 87–97, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. J. D. Ly, D. R. Grubband, and A. Lawen, “The mitochondrial membrane potential (ψm) in apoptosis; an update,” Apoptosis, vol. 8, no. 2, pp. 115–128, 2003. View at Google Scholar
  44. E. Gottlieb, S. M. Armour, M. H. Harris, and C. B. Thompson, “Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis,” Cell Death and Differentiation, vol. 10, no. 6, pp. 709–717, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Ozao-Choy, R. D. Carvajal, and O. Hamid, “Ipilimumab for metastatic melanoma,” Drugs of Today, vol. 48, no. 6, pp. 381–393, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. D. Davar, A. A. Tarhini, and J. M. Kirkwood, “Adjuvant therapy for melanoma,” Cancer Journal, vol. 18, no. 2, pp. 192–202, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Bernatchez, L. G. Radvanyi, and P. Hwu, “Advances in the treatment of metastatic melanoma: adoptive T-cell therapy,” Seminars in Oncology, vol. 39, no. 2, pp. 215–226, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. H. J. Gogas, J. M. Kirkwood, and V. K. Sondak, “Chemotherapy for metastatic melanoma: time for a change?” Cancer, vol. 109, no. 3, pp. 455–464, 2007. View at Publisher · View at Google Scholar · View at Scopus